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a b s t r a c t
Cell fate decisions during embryogenesis and adult life govern tissue formation, homeostasis and repair.
Two key decisions that must be tightly coordinated are proliferation and differentiation. Overprolifera-
tion can lead to hyperplasia or tumor formation while premature differentiation can result in a depletion
of proliferating cells and organ failure. Maintaining this balance is especially important in tissues that
undergo rapid turnover like skin however, despite recent advances, the genetic mechanisms that balance
cell differentiation and proliferation are still unclear. In an unbiased genetic screen to identify genes
affecting early development, we identiﬁed an essential regulator of the proliferation–differentiation
balance in epidermal progenitor cells, the Keratinocyte differentiation factor 1 (Kdf1; 1810019J16Rik) gene.
Kdf1 is expressed in epidermal cells from early stages of epidermis formation through adulthood.
Speciﬁcally, Kdf1 is expressed both in epidermal progenitor cells where it acts to curb the rate of
proliferation as well as in their progeny where it is required to block proliferation and promote
differentiation. Consequently, Kdf1 mutants display both uncontrolled cell proliferation in the epidermis
and failure to develop terminal fates. Our ﬁndings reveal a dual role for the novel gene Kdf1 both as a
repressive signal for progenitor cell proliferation through its inhibition of p63 and a strong inductive
signal for terminal differentiation through its interaction with the cell cycle regulator Stratiﬁn.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The appropriate balance between cell division and differentia-
tion is crucial for organ formation during development as well as
for tissue maintenance postnatally. Excessive proliferation or defec-
tive differentiation can lead to tumor formation, while the inverse
scenario can result in hypoplastic organs or defects in tissue repair.
Stem cells are key to maintaining tissue integrity, acting as a
reservoir to produce new progeny cells that will differentiate to
replace damaged or lost tissue. Adult mammalian skin is the largest
organ in the body and comprises a thin, external epidermis and an
underlying, thicker dermis. The epidermis has been an excellent
model to deﬁne the cellular interactions and genetic factors
regulating this delicate balance of stem cell proliferation and
differentiation, as this tissue is turned over approximately every
4–6 weeks in humans and between 1.5 and 2 million skin cells are
sloughed off every hour (Milstone, 2004). Without replacement, the
epidermis and the barrier it provides would rapidly be depleted.
Establishment of the epidermis occurs during embryonic develop-
ment, where epidermal progenitor cells give rise to a fully func-
tional epidermis by birth. Thus, the coordination of proliferation
and differentiation within the epidermal progenitor cells is also
essential for epidermis formation and function.
During embryonic development, the undifferentiated ectoderm
becomes committed to the epithelial lineage by embryonic day
(e) 8.5 (Byrne et al., 1994). A few days later, (around e13.5)
stratiﬁcation begins, giving rise to a distal layer of epidermal cells
(keratinocytes) called intermediate cells that continue to prolifer-
ate but also begin to express the ﬁrst markers of differentiation
(Byrne et al., 1994; Lechler and Fuchs, 2005; Smart, 1970). Inter-
mediate cells are a transient embryonic epidermal population that
retain the ability to divide, but later differentiate into non-
proliferative spinous cells by e15.5 (Koster et al., 2007; Weiss
and Zelickson, 1975). From this stage onward, proliferation is
restricted to the basal layer of the epidermis (Byrne et al., 2003;
Fuchs, 2008; Koster and Roop, 2007). As cells leave the basal
layer, they undergo sequential differentiation to produce spinous,
granular and corniﬁed layers, which are eventually shed via
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desquamation (Fuchs and Horsley, 2008; Milstone, 2004). Disrup-
tion in the formation of these layers or connections between them
can lead to a host of defects including lethal dehydration and
microbial infection. Despite recent advances in epidermal biology,
our understanding of epidermis formation and homeostasis,
particularly in regards to the genes that regulate epidermal
progenitor cell proliferation and differentiation is quite limited.
One factor that is essential for normal stratiﬁcation of the
epidermis is the cell cycle regulator Stratiﬁn (14-3-3s, Sfn).
Although initially studied for its role in DNA damage response
(Chan et al., 1999, 2000), Sfn was later shown to promote
differentiation of suprabasal cells. Mouse embryos homozygous
for a mutation in Sfn develop a thick, hyperplastic epidermis and
keratinocytes fail to differentiate into granular or corniﬁed cells
(Guenet et al., 1979; Herron et al., 2005; Li et al., 2005). Instead, all
suprabasal layers express spinous markers while remaining pro-
liferative, suggesting that these cells are locked into the inter-
mediate fate. A key regulator of Sfn is p63 (Dohn et al., 2001;
Westfall et al., 2003), the ﬁrst transcription factor expressed
speciﬁcally in epithelial cells that have adopted an epidermal fate.
At later stages, p63 is expressed primarily by basal keratinocytes
and plays multiple roles during epidermis development (Green
et al., 2003; Koster et al., 2004). p63 inhibits the expression of Sfn
in basal cells and also promotes their proliferation such that loss of
p63 results in a thin but differentiated epidermis (Mills et al., 1999;
Yang et al., 1999). However, only a handful of factors that interact
with Sfn or p63 to control proliferation and differentiation during
embryonic epidermis formation are known.
Forward genetics is a powerful, unbiased tool to identify novel
genes with essential roles in biological processes. Using this
approach, we uncover a previously unknown but essential reg-
ulator of the proliferation–differentiation balance in epidermis, the
Keratinocyte Differentiation Factor 1 (Kdf1; 1810019J16Rik) gene.
Here we demonstrate that mice carrying mutations in Kdf1 display
uncontrolled proliferation of basal progenitor cells and a failure of
their progeny to differentiate. This results in a thickened, but non-
functional epidermis. Our results further reveal that Kdf1 represses
basal cell proliferation by inhibiting p63 and also closely interacts
with the cell cycle regulator Sfn to induce terminal differentiation
in suprabasal cells. These results identify Kdf1 as a critical negative
regulator of keratinocyte proliferation during epidermis develop-
ment and an essential factor in the differentiation of epidermal
progenitor cell progeny.
Materials and methods
Mouse strains
SfnEr (Guenet et al., 1979) mice were kindly provided by M.
Karin. The p63Brdm2 line was obtained from JAX. We genotyped
mutant alleles as previously described (Herron et al., 2005; Li
et al., 2005; Mills et al., 1999) and see Supplementary Fig. 5. We
obtained ES cells harboring a targeted allele of Kdf1
(1810019J16Riktm1a(EUCOMM)Wtsi) from the International Knockout
Mouse Consortium in order to generate the Kdf1 gene trap line
(Kdf1GT). This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The protocol was
approved by Institutional animal care and use committee (IACUC
protocol number 2010–11172).
Mutagenesis screen
C57BL/6J and C3HeB/FeJ mice were obtained from The Jackson
Laboratory. ENUmutagenesis was performed essentially as described
(Kasarskis et al., 1998). 10 mg/ml ENU in phosphate–citrate buffer
was injected intraperitoneally into male mice 9–10 weeks old at the
time of the ﬁrst injection. C57BL/6J males received ENU in three
doses of 100 mg/kg body weight administered once a week for
3 weeks. These males were used to establish lines by crossing to
C3HeB/FeJ females. Each resulting F1 male was mated to two C3HeB/
FeJ females, to generate second-generation (G2) females. Four to 10
G2 females per line were mated to the F1 male; lines with two or
more litters containing embryos with similar abnormal morphology
were considered potentially mutant. G2 males and females from
these lines were produced and intercrossed, and litters were
screened at 12.5 days post coitum to conﬁrm the heritability of the
phenotype and to identify G2 males that carried the mutation. Lines
were maintained initially by outcrossing the carrier males to C3HeB/
FeJ, intercrossing the resulting progeny, and examining embryos to
identify new male carriers. After the mutation responsible for the
phenotype was initially mapped, carriers of both sexes were identi-
ﬁed by PCR as those carrying the C57BL/6J alleles of markers ﬂanking
the induced mutation.
Mapping of shd
The shd mutant was initially identiﬁed based on a short limb/
snout phenotype at e12.5. Initial mapping of the shd mutation
utilized two to ﬁve simple-sequence length polymorphism mar-
kers per chromosome to identify linkage between the epidermis
phenotype and C57BL/6J DNA polymorphisms. Linkage to Chromo-
some 4 was established and subsequently the shd interval was
narrowed to between markers D4Mit204 (132.98 Mb) and D4SKI3
(134.16 Mb; https://mouse.mskcc.org). The shd mutation was
crossed 411 generations onto the C3HeB/FeJ background, which
removed more than 99.9% of the original mutagenized C57BL/6J
background, supporting the idea that the shd phenotype is mono-
genic. Characterization of the shd phenotype occurred on a mixed
C57BL/6J–C3HeB/FeJ background.
Sequence capture
The basic principle of Sequence Capture has been previously
described (Hodges et al., 2007; Olson, 2007). In our study, a
Nimblegen mouse Sequence Capture 385K array was designed to
contain oligos complementary to all exons and splice sites within
the shd interval. Genomic DNA was isolated from an e11.5 shd
homozygote, and then sheared by sonication and adaptors were
ligated to the resulting fragments. The adaptor-ligated templates
were fractionated by agarose gel electrophoresis and fragments of
the desired size were excised. Extracted DNA was ampliﬁed by
ligation-mediated PCR, puriﬁed, and hybridized to the capture
array. The array was washed, and bound DNA was eluted, puriﬁed,
and ampliﬁed by ligation-mediated PCR (similar to methods
employed in Choi et al. (2009)). The capture and sequencing
experiments were performed at the W.M. Keck Foundation for
Biotechnology Resources at Yale. This array also contained
sequences from Chromosomes 11 & 7, unrelated to shd. For details
about these sequences, please contact the authors.
Sequencing and mutation analysis
Captured libraries were sequenced on an Illumina Genome
Analyzer II as single-end, 75-bp reads, as previously described
(Choi et al., 2009). Illumina reads were ﬁrst trimmed based on
their quality scores to remove low-quality regions using the
program Btrim (Kong, 2011). A cutoff of 20 for average quality
scores within a moving window of size 5-bp was used. Mini-
mum acceptable read length was set to 25-bp. Other parameters of
Btrim were set to defaults. The pre-processed reads were then
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aligned to the mouse genome reference sequence (mm9) using the
Burrows-Wheeler Alignment tool (Li and Durbin, 2009). The
mapping results were converted into SAMtools pileup format
using SAMtools programs (Li et al., 2009). PCR duplicates were
removed using the rmdup command from SAMtools. SNVs were
called using SAMtools' pileup command. Further ﬁltering was
performed using in-house scripts to exclude those SNV calls that
had fewer than 3 reads or a SNP score less than 20. Annotationwas
added based on the UCSC RefSeq gene model (http://genome.ucsc.
edu/) (Pruitt et al., 2009). Following the identiﬁcation of the shd
mutation, we designed primers to discriminate the mutation from
wild-type sequence by PCR followed by restriction enzyme diges-
tion (Supplemental Fig. 4).
Expression and histological analyses
Hematoxylin/Eosin staining, in situ hybridizations, skeletal
staining and immunoﬂuorescence analyses were performed using
standard methods (Nagy et al., 2002). Toluidine Blue dye exclusion
assays were performed at e18.5 as previously described (Hardman
et al., 1998). X-gal staining of genetrap heterozyogotes was
performed as previously described (Nagy et al., 2002). Antibodies
used for immunostaining included Keratin 10, Keratin 14, Filag-
grin, Loricrin (all from Covance), phosphorylated Histone H3
(Millipore), p63 (BD Pharmingen, 559951), Kdf1 (Sigma Prestige
Antibody HPA028639); raised against the human ortholog (Uhlen
et al., 2005), Rhodamine–Phalloidin (Molecular Probes/Invitrogen)
and CD104/β4 integrin (BD biosciences).
RNA extraction and real-time PCR
The epidermis was isolated from e18.5 embryos and total RNA
was extracted using Trizol reagent (Invitrogen, Carlsbad, CA) and
RNeasy kit (Quiagen). RNA was treated with DNaseI and RT-PCR
was performed on 2 μg of total RNA using a Superscript ﬁrst-
strand cDNA synthesis kit (Invitrogen) according to the manufac-
turer's instructions. The resulting cDNA was diluted 1:5 in
nuclease-free water and stored in aliquots at –80 1C until used.
Real-time PCR with SYBR green detection (Roche) was performed
using a ViiA7 thermocycler (Invitrogen). The following primers
were used:
GAPDH Forward: 5' TGATGACATCAAGAAGGTGGTGAAG 3',
GAPDH Reverse: 5' TCCTTGGAGGCCATGTAGGCCAT 3',
pan p63 Forward: 5' AGATCCCTGAACAGTTCCGAC 3',
pan p63 Reverse: 5' ATCGATCACACGTTCACCAC 3',
DNp63 Forward: 5' CTGGAAAACAATGCCCAGAC 3'
DNp63 Reverse: 5' GAGGAGCCGTTCTGAATCTG 3',
Sfn Forward: 5' TCGCACCTCATCAAAGGGG 3',
Sfn Reverse: 5' CGGCTAGGTAGCGGTAGTAG 3'.
The experiments were carried out in triplicate for each data
point. The relative quantiﬁcation in gene expression was deter-
mined using the 2-ΔΔCt method (Livak and Schmittgen, 2001).
Using this method, we obtained the fold changes in gene expres-
sion normalized to an internal control gene (GAPDH).
Mitotic index analysis
Transverse sections of e12.5 and e16.5 embryos were processed
through standard immunostaining protocols. The mitotic index
was calculated as the ratio of phosphorylated Histone H3 (PHH3)-
positive cells to all nuclei in the basal or suprabasal layer of the
lateral epidermis, as appropriate. All data were collected from
multiple embryos (e12.5: control n¼5, shd / n¼4; e16.5: control
n¼4, shd/n¼5, shd/;p63þ /n¼5). For quantiﬁcation of the
mitotic index, between 720 and 1100 basal keratinocytes (e12.5),
800 and 2100 basal keratinocytes (e16.5) and between 3700 and
5800 suprabasal cells (e16.5) were scored. The results were
expressed as mean7standard deviation and statistical signiﬁ-
cance was measured using an unpaired two-tailed Student T-test
with equal variance.
Isolation of primary keratinocytes and transient transfection
Primary keratinocytes were isolated from e18.5 epidermis and
cultured following previously described methods (Nowak and
Fuchs, 2009). To test antibody speciﬁcity, primary keratinocytes
were plated onto glass cover slips and transfected with full length
Kdf1 with a C-terminal or N-terminal GFP tag. Both constructs
showed the same expression pattern. CMV-GFP and K14-GFP were
used as transfection controls. Transient transfection was per-
formed using Lipofectamine LTX (Invitrogen) or Fugene 9 reagent
(Promega) according to manufacturer's instructions. After 24 h,
cover slips were subjected to standard immunostaining proce-
dures and stained for Kdf1 or Rhodamine–phalloidin together
with DAPI.
Results
Identiﬁcation of a recessive, perinatal lethal mouse mutant with
epidermal defects
To uncover new factors that regulate cell fate decisions during
embryonic development, we performed an unbiased N-ethyl-N-
nitrosourea (ENU)-induced mutagenesis screen in mice and scored
for morphological defects at embryonic day (e) 12.5. We identiﬁed
a recessive mutant with a short snout and short limbs (Fig. 1A–C),
which we designated shorthand (shd). To further examine the
phenotype, we analyzed litters at e18.5. At this late stage, shd
mutants appeared to lack ears or a mouth opening, exhibited short
forelimbs, and showed fusion between the tail, hindlimbs and
genitals (Fig. 1D). Skeletal analysis revealed the presence of all
limbs and the tail in shd mutants (not shown), but the lack of
protrusion of the hindlimbs and tail appeared to result from an
overgrowth of the epidermis that fused them to the body pre-
senting a smooth, taut surface. Internal organs and muscles were
not obviously affected but shd homozygotes died at birth, likely
due to the epidermis covering the mouth and nose openings,
preventing respiration. shd heterozygous animals were viable,
fertile and were phenotypically indistinguishable from wild-type
littermates.
shd mutants display keratinocyte defects leading to thickened
epidermis and defective epidermal barrier formation
shd mutants possessed a shiny and taut epidermis and, but it
was unclear if the epidermis was functional. One measure of
epidermal integrity is the formation of an outside–in barrier that
keeps the external environment from penetrating the skin. To test
if this barrier formed normally in shd mutants, we challenged
themwith a dye that cannot penetrate mature epidermis. At e18.5,
wild-type and heterozygote animals had developed a watertight
epidermal barrier, but in shd mutants, we observed global dye
penetration indicating a defective epidermal barrier (Fig. 1E and
not shown). The overall gross morphological phenotype and fail-
ure to form a competent barrier prompted us to examine the
epidermis in greater detail. Histological analysis of sections
through dorsal skin conﬁrmed our initial observation of shd
mutant skin being taut and lacking wrinkles. In addition, we
observed that the epidermis was 2–10 thicker than in controls
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(Fig. 1F). Moreover, even though an apparent basal layer was
present, more differentiated keratinocytes were poorly deﬁned
compared to wildtype, which are organized into distinct stratiﬁed
layers (spinous, granular and corniﬁed). As keratinocytes progress
through terminal differentiation, they undergo corniﬁcation and
lose their nuclei. However, in shd mutants, the most distal
keratinocytes still retained their nuclei and the epidermis showed
no signs of a corniﬁed layer (Fig. 1G). To test if the shd mutation
only affected epidermal keratinocytes, we also examined the oral
cavity and esophagus, which are lined with keratinocytes.
We observed complete fusions of the esophageal epithelium,
resulting in no lumen (Fig. 1H). In addition, shdmutants developed
cleft palate (Fig. 1I) due to a fusion of the tongue and palate shelf
epithelium, suggesting a widespread defect in keratinocyte
development.
The shd gene is required for the differentiation of basal keratinocyte
progeny
We decided to focus our efforts on understanding the effects of
the shd mutation on the development of epidermal keratinocytes.
The epidermis comprises a proliferative basal layer and progres-
sively differentiated spinous, granular and corniﬁed keratinocyte
layers. To analyze the differentiation of individual cell types in shd
epidermis, we examined markers of different stages of epidermal
keratinocyte differentiation. Several lines of evidence indicated
a failure of terminal differentiation in shd mutants. First, basal
markers Keratins 14 and 5 were expressed throughout shd
epidermis in contrast to their restricted expression to basal
keratinocytes in controls (Fig. 2A and not shown). In addition,
although the spinous marker Keratin 10 was induced as cells
Fig. 1. shd mutants display multiple defects linked to keratinocytes. (A–C) Gross morphological comparison of wild-type and shd mutant embryos at e12.5. shd mutants
display shortened and fused limbs (B) and craniofacial malformations, including shortened snout (C). (D) Gross appearance of wild type and shd mutants at e18.5, showing a
smooth skin and fusion between hindlimbs and tail. (E) Toluidine Blue exclusion assays of whole embryos show a breakdown in the epidermal barrier in shd homozygotes.
(F–G) Hematoxylin and eosin-stained sections of back skin showing a thickened epidermis in shd mutants and retention of nuclei in distal keratinocytes (G, arrows).
(H) Sections through the esophagus reveal an absence of a lumen (lu) in shd homozygotes and apparent fusion between the keratinocytes (E-Cadherinþ) lining the
esophagus. (I) Hematoxylin and eosin-stained sections through heads showed that the palatal shelves (ps) do not fuse along the midline in shd mutants, but instead appear
fused to the tongue, resulting in cleft palate. Scale bars: 1 mm (A–C) 5 mm (D, same for E), 50 um (F,G), 20 um (H), 100 um (I). Yellow dotted lines in F, G mark the dermis
(lower) and epidermis (upper) boundary.
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exited the basal layer, its domain was expanded distally (Fig. 2B)
and overlapped with basal marker expression in shd mutants,
suggesting these cells possessed a mixed identity. Finally, the
granular and corniﬁed markers Loricrin and Filaggrin were
strongly reduced or absent in shd mutants (Fig. 2C,D). Together,
these results demonstrate that the gene affected in shd mutants is
essential for the normal differentiation of basal progenitor cell
progeny. Instead, suprabasal cells in shd mutants express a mix of
basal and spinous markers.
Suprabasal keratinocytes retain proliferative potential in shd mutants
While all epidermal keratinocytes initially have the potential
to proliferate, this feature is restricted at later stages to the basal
cell layer. As the progeny of basal cells enter the suprabasal layer,
they quickly lose the ability to divide and begin to differentiate.
The thickened epidermis in shd mutants led us to question
whether dysregulated proliferation might also contribute to the
skin phenotype. We found that proliferation was no longer
restricted to the basal layer and that suprabasal keratinocytes
continued to divide (Fig. 2E,F). In fact, shd mutant suprabasal cells
showed 70-fold increase in their mitotic index compared to
controls (2.11% vs. 0.03%, Fig. 2H). Consistent with this observation,
shd mutant epidermis showed ectopic Keratin-6 immunoreactivity
(Fig. 2G), which is observed in hyperproliferative epidermis (Fuchs,
1995; Navarro et al., 1995). Together, our data demonstrate a
breakdown in the switch from proliferative basal cells to differ-
entiated, postmitotic progeny in shd mutants. The result is a
hyperthickened, poorly-differentiated epidermis that fails to form
a normal barrier.
The Stratiﬁn tumor suppressor gene interacts with shd
The cell cycle regulator Stratiﬁn (Sfn; 14-3-3s) is a key
modulator of cell differentiation in the epidermis (Bhatia et al.,
2003; Dellambra et al., 1995). The Sfn gene is mutated in Repeated
Epilation (Er) animals, and Er homozygotes phenocopy shd
mutants (Guenet et al., 1979; Herron et al., 2005; Li et al., 2005).
Like shd mutants, Er homozygotes are perinatal lethal and mutant
embryos develop a thickened epidermis that lacks differentiation
markers (ex. Loricrin, Filaggrin) but instead shows expanded basal
(K14) and spinous (K10) markers. (Guenet et al., 1979; Herron
et al., 2005; Li et al., 2005). One possible explanation for the shd
phenotype is that Sfn might act downstream of the shd gene to
Fig. 2. The shd mutation causes hyperproliferation and defective differentiation of the epidermis. Analysis of e18.5 (A–G) shd epidermis. Basal (A, Keratin 14 in red) and
spinous (B, Keratin 10 in red) cell markers are expressed in the distally expanded keratinocytes in shd epidermis. Markers of granular and corniﬁed layers (C, Filaggrin in red;
D, Loricrin in red) are largely absent in shdmutants. shd epidermis is hyperproliferative, expressing the mitotic markers Ki-67 (E, green) and phospho-HistoneH3 (F, green) in
suprabasal layers (arrows) expressing K10 (E, red), whereas proliferation is restricted to basal layers in controls. Keratin-6 is absent under normal conditions (G) and only
induced under hyperproliferative conditions, such as in shd epidermis. (H) Quantiﬁcation of the mitotic index in the suprabasal cells at e16.5. DAPI is shown in blue (A–G).
Asterisks mark unspeciﬁc trapping of the secondary antibody in the corniﬁed layer. The dotted lines (B, E, G) or β4 integrin staining (A, C, D, F) mark the border between the
epidermis and dermis. Scale bar represents 20 um for all panels.
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regulate keratinocyte proliferation and differentiation. If so, then
we would expect to see reduced levels of Sfn in shd mutant
epidermis. In contrast, we found that Sfn is now expressed
throughout the epidermis in shd mutants (Fig. 3A), and Sfn
transcript levels are increased approximately 3 fold (Fig. 3B), as
assayed by quantitative real-time reverse transcriptase PCR (qRT-
PCR). These data argued against the possibility that Sfn acts
downstream of shd and instead suggested that Sfn and shd act
together to regulate proliferation and differentiation.
To test for a potential genetic interaction between Sfn and
shd we analyzed doubly heterozygous animals (shdþ /;Erþ /). We
recovered only a single shdþ /;Erþ / adult out of 51 animals
(2% instead of the expected 25%), indicating a postnatal lethal
interaction. Focusing on embryonic development, we recovered
shdþ /;Erþ / embryos at normal Mendelian ratios (n¼7/32; 22%)
however, they displayed cleft palate and fusions within the oral
cavity, similar to shd or Er homozygotes (Fig. 3C). When we tested
for epidermal barrier function we observed that shdþ /;Erþ /
embryos showed barrier defects in several regions (Fig. 3D,E).
As mentioned previously, shdþ / carriers did not show barrier
defects, however Erþ / embryos displayed abnormal barrier for-
mation around the eyelids, ears, snout and digit/tail tips (Fig. 3E).
This is likely a delay in barrier formation as Erþ / heterozygotes
are viable and appear normal at birth. In shdþ /;Erþ / embryos,
while most regions of the epidermis show normal barrier forma-
tion, we observed more pronounced barrier defects around the
eyelids, ears, snout and digit/tail tips than in Erþ / heterozygotes
(Fig. 3E), suggesting Sfn and shd cooperate to ensure normal
barrier formation.
We noticed additional regions with abnormal barrier formation
in shdþ /;Erþ / embryos including under the chin as well as
in two dorsal stripes (Fig. 3D,E). When we sectioned through
the dorsal stripes, we found that the barrier defect appeared
to be caused by breaks in the corniﬁed layer. Most regions of
shdþ /;Erþ / embryos form normal epidermis, including a corni-
ﬁed layer. In the barrier-defective stripe regions, we found the
epidermis was greatly thickened and the corniﬁed layer (high-
lighted by trapping of β4 integrin staining, marked by asterisks)
Fig. 3. Er-shd double heterozygotes develop cleft palate and epidermal differentiation defects. (A) in situ hybridization for Sfn (blue) at e18.5 shows expanded expression in
shd epidermis. (B) qRT-PCR reveals elevated Sfn transcript levels in shd epidermis. (C) Alcian blue and Fast Red-stained sections through e18.5 heads show that the palatal
shelves (ps) elevate and fuse normally in Er heterozygotes but do not fuse along the midline in shd-Er double heterozygotes, resulting in cleft palate. (D,E) Dye exclusion
assays show a delay in barrier formation in Er heterozygotes and a more pronounced epidermal barrier defect in shdþ /;Erþ / animals including stripes in caudal back skin
(D) and around the eyes, ears, snout, limbs and tail (E). Sections through the barrier-defective dorsal epidermis show that the epidermis is thickened in these regions (F–I)
and that basal (F, K14) and spinous (G, K10) markers are abnormally expanded in distal shdþ /;Erþ / keratinocytes. Terminal differentiation markers (E,F) are expressed in
shdþ /;Erþ / keratinocytes, but are co-expressed in with K14 and K10. β4 integrin staining marks the border between the epidermis and dermis (F–I). DAPI is shown in blue
(F–I). Scale bars represent 50 μm (A), 250 μm (C), 2 mm (D), 5 mm (E), 20 μm (F–I).
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Fig. 4. The shd mutation acts through p63 to regulate basal proliferation and epidermal differentiation. (A) Early epidermis is largely single layered, but shd mutants show
extra layers by e12.5. (B) At e14.5, the intermediate keratinocyte layer is largely Keratin14-negative in wild type, but dorsal epidermis in shdmutants is greatly thickened and
retains Keratin14 (red) expression. (C) Basal proliferation is already increased at e12.5 in shdmutants (4.48%70.61%) compared to control littermates (2.83%70.44). (D) qRT-
PCR shows a two-fold upregulation of p63 in shd epidermis, which is mainly due to the ΔNp63 isoform. (E) Dye exclusion assay shows a rescue of epidermal barrier
function in shd / ;p63þ / embryos, especially in lateral regions. (F) Basal progenitor cell proliferation is doubled in shdmutants (4.21%70.55; n¼5 embryos) compared to
controls (1.95% 70.34; n¼4) at e16.5 and rescued by reducing p63 dosage in shd /;p63þ / embryos (2.00% 70.47; n¼5). Error bars: st.dev.; statistical signiﬁcance was
measured using an unpaired two-tailed Student T-test with equal variance. ***P o 0.001. (G) At e18.5, p63 protein expression is expanded throughout shd mutant epidermis
and restored to wild-type in shd/; p63þ / compound mutants. (H–K) Sections of shd /;p63þ / lateral back skin show normal epidermis thickness. Basal (H, Keratin 14
in red) and spinous (I, Keratin 10 in red) cell markers are restricted to their normal domains and expression of more differentiated markers is rescued (J, Loricrin in red; K,
Filaggrin in red) in shd /;p63þ / embryos. (L) p63 expression is greatly expanded in caudal regions of the backskin in shdþ /; Erþ / transheterozygotes which lacked
proper barrier function (see Fig. 3E). p63 expression in lateral regions of shdþ /; Erþ / embryos appears similar wild type and to Erþ / animals (not shown). β4 integrin
staining marks the border between the epidermis and dermis (B, G–L). Yellow asterisks mark unspeciﬁc trapping of secondary antibody in corniﬁed layer. DAPI is shown in
blue (A,B, G–L). Control and mutant samples are shown at the same magniﬁcation. Scale bars represent 20 μm (A,B, G–L), 5 mm (E).
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displayed gaps, with keratinocytes spilling out onto the surface of
the embryo (see Fig. 3F–I). When we assayed the identity of the
keratinocytes in the barrier-defective stripes, we found that the
epidermis had a clear basal layer (K14þ , K10; Fig. 3F,G) but
more distal cells were co-expressing basal, suprabasal, and more
differentiated markers simultaneously (Fig. 3F–I). This phenotype
is distinct from shd or Er single homozygotes and shows that in
some regions of shdþ /;Erþ / epidermis, differentiation proceeds
without turning off basal markers. This suggests that the shd gene
and Sfn act together to inhibit basal markers and coordinate the
stepwise differentiation of basal cell progeny, at least in a subset of
the epidermis.
Basal cell proliferation is increased in shd mutants
shd mutant keratinocytes simultaneously expressed both basal
(K14) and spinous (K10) markers in distal layers, while remaining
mitotically active. These features are a hallmark of the transient
embryonic cell population called intermediate keratinocytes found
at e14.5 (Smart, 1970; Weiss and Zelickson, 1975). This led us to
hypothesize that shd keratinocytes become trapped in the inter-
mediate cell fate and fail to terminally differentiate. If this were
true, we would expect that (1) shd mutants would not show a
defect prior to the establishment of intermediate cells, and
(2) basal cells would not be affected by the shdmutation. However,
we observed premature epidermal thickening by e12.5 in shd
mutants (Fig. 4A), leading to greatly thickened dorsal epidermis by
the time of intermediate identity establishment (Fig. 4B). We
further observed a signiﬁcant increase in shd basal keratinocytes
that were actively dividing compared to controls (2.82% in control
compared to 4.48% in shd mutants) at e12.5 (Fig. 4C). These data
indicate that the shd gene normally acts within the basal layer as a
brake on epidermal progenitor cell proliferation and when dis-
rupted leads to extensive early epidermis overgrowth.
shd acts upstream of p63 to regulate epidermal proliferation and
differentiation
p63 is a member of the p53 tumor suppressor gene family that
is expressed primarily by basal keratinocytes and plays multiple
roles during epidermis development (Green et al., 2003; Koster
et al., 2004). Loss of p63 function results in the opposite pheno-
type of shd homozygotes, namely a thin but differentiated epider-
mis (Mills et al., 1999; Yang et al., 1999). This highlights one of the
key roles of p63, namely that it promotes proliferation of basal
keratinocytes (Truong et al., 2006). Since we observed an increase
in the mitotic index of shd keratinocytes at e12.5 (Fig. 4C), we
tested whether this might be due to an increased level of p63. qRT-
PCR assays on e18.5 epidermis showed that p63 transcript levels
were increased approximately 2-fold in shd mutants compared to
controls (Fig. 4D) and that these transcripts are almost exclusively
ΔNp63, the main epidermal isoform of p63, which is normally
restricted to basal keratinocytes (Romano et al., 2009). Further,
using a pan-p63 antibody, we found that p63 was no longer
restricted to basal keratinocytes in shd embryos, but was now
expressed throughout the epidermis (Fig. 4G). These results
suggested the possibility that increased levels of p63 might
underlie the shd phenotype.
To test the hypothesis that elevated p63 levels drive part of the
shd mutant phenotype, we set out to lower p63 gene dosage in the
shd background. We ﬁrst generated shdþ /;p63þ / double hetero-
zygotes. shdþ /;p63þ / animals were viable, fertile and did not
display any gross epidermal or hair defects (not shown). The p63
locus is located on Chromosome 16 in the mouse, and we had
mapped the shd mutation to Chromosome 4 (see Methods),
allowing us to make compound mutants without concerns about
linkage. We subsequently crossed these double heterozygotes to
shdþ / carriers in order to examine the phenotype of the com-
pound mutant (shd /;p63þ /) mice. Strikingly, we found that
many aspects of the shd phenotype were rescued by reducing the
dosage of p63. The epidermal barrier formation was rescued in
most regions of the compound mutants as well as the limb
protrusion defects and tail–hindlimb fusion normally observed in
shd mutants (Fig. 4E). When we examined basal keratinocyte
proliferation, we found that the 2-fold increased mitotic index
in shd mutants was rescued in shd /;p63þ / embryos (Fig. 4F).
Further, normal epidermis thickness was restored in lateral (bar-
rier-restored) regions of shd /;p63þ / mutants, and p63 was
now restricted to basal keratinocytes (Fig. 4G). Whenwe examined
differentiation markers in the epidermis of shd /;p63þ /
mutants, we found that early and late differentiation markers
were expressed normally (Fig. 4H–K).
Sfn has also been shown to inhibit p63 in keratinocytes
(Li et al., 2011). We then tested whether Sfn and shd might
cooperate to regulate p63. When we examined lateral (i.e. pheno-
typically wild type) regions of shdþ /;Erþ / epidermis we
observed normal restriction of p63 to basal keratinocytes. How-
ever, we observed a dramatic expansion of p63 throughout the
epidermis in the barrier-defective dorsal stripes (Fig. 4L). This
demonstrates that shd and Sfn can act together to inhibit p63 and
allow normal epidermal differentiation. Taken together, these
results demonstrate that the shd gene functions to inhibit p63 in
the epidermis. Both the block of terminal differentiation as well as
the increase in basal progenitor cell proliferation in shd mutants
appears to be due to excess p63.
The shd mutation affects a previously unknown epidermal regulator,
1810019J16Rik
To identify the gene affected by the shd mutation, we initially
mapped the shd mutation to a region of mouse Chromosome
4 that is syntenic to human Chromosome 1p36, which has been
intensely studied due to developmental phenotypes and skin
cancers associated with haploinsufﬁciency in this region (Bagchi
and Mills, 2008; Campeau et al., 2008; Gajecka et al., 2007). Using
a targeted capture and sequencing approach, we identiﬁed a
homozygous mutation in shd animals within the previously
uncharacterized 1810019J16Rik gene, which we have renamed
Keratinocyte differentiation factor 1 (Kdf1). shd mutants contain a
T4G transversion within intron 2 of Kdf1, 14 bases upstream of
exon 3 (Fig. 5A). This changed an AT site to AG, raising the
possibility that this might be recognized by the splicing machinery
as a splice acceptor. To test this, we performed RT-PCR and found
that the shd mutation eliminates the wild-type transcript by
altering splicing and results in two shd-speciﬁc splice variants.
(Fig. 5B). One splice variant utilizes the mutation as a new splice
acceptor site, resulting in an out of frame, but longer transcript.
The other splice variant skips exon 3 altogether, resulting in an in-
frame deletion (Fig. 5C).
The Kdf1 gene is unique within the mouse genome but lacks
any recognizable protein domains, with the exception of proline
and cysteine-rich domains near the N-terminus (Fig. 5D). The shd-
speciﬁc transcripts should give rise to two protein variants, one
with a C-terminal frameshift and one with an internal deletion
(Fig. 5D, Supplemental Fig. 1). . The Kdf1 protein shares 90%
identity with the human homolog (C1ORF172) and is highly
conserved across mammals (Supplemental Fig. 2). This conserva-
tion falls off outside of mammals, but orthologs of Kdf1 have been
isolated in multiple vertebrate lineages including birds, amphi-
bians and ﬁsh (Supplemental Fig. 3). The C-terminal portion of the
protein, which is affected in shd mutants, is particularly well
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conserved in mammals suggesting this region is vital for gene
function.
A complementation test conﬁrms the identity of the shd gene
We validated the Kdf1 mutation by standard Sanger sequencing
in multiple shdmutants; however it was possible that this mutation
was merely linked to the shd phenotype instead of being causative.
To verify that loss of function of the Kdf1 gene underlies the shd
phenotype, we generated mice carrying a targeted gene trap allele
of Kdf1 from embryonic stem cells (1810019J16Riktm1a(EUCOMM)Wtsi;
Kdf1GT). Kdf1GT/þ heterozygotes were viable and non-phenotypic.
Our characterization of Kdf1GT/GT homozygotes showed epidermal
barrier defects (Fig. 6) and abnormal differentiation similar to shd
mutants. This suggested that the two recessive mutations might
affect the same gene; however these two mutations could produce
the same phenotype but affect different genes. To discriminate
Fig. 6. A second Kdf1 allele fails to complement the shd phenotype verifying that
Kdf1 is the affected gene in shd mutants. (A) Dye exclusion assay at e18.5
demonstrating the failure of Kdf1 gene trap homozygotes (Kdf1GT/GT) and shd-Kdf1
gene trap transheterozygotes (Kdf1GT/shd) to establish a functional epidermal
barrier. Basal (B, Keratin 5 in red) and spinous (C, Keratin 10 in red) cell markers
are expanded in keratinocytes in Kdf1GT homozygote embryos as well as in Kdf1GT/
shd transheterozygotes. Markers of granular and corniﬁed layers (D, Loricrin in red;
E, Filaggrin in red) are not induced in Kdf1GT homozygote embryos and in shd–
Kdf1GT transheterozygotes. This failure of the two alleles to complement demon-
strates that the shd phenotype derives from a mutation in the Kdf1 gene. β4 integrin
staining marks the border between the epidermis and dermis (B–E). DAPI is shown
in blue (B–E). Asterisks marks unspeciﬁc antibody trapping. Control and mutant
samples are shown at the same magniﬁcation. Scale bar represents 5 mm (A),
20 um (for B–E; shown in E).
Fig. 5. Identiﬁcation of a point mutation within the 1810019j16Rik locus, causing
splicing defects in shd mutants. (A) Sequence traces from wild type, heterozygous
and homozygous shd embryos. In shd mutants and carriers, there is a T4G
transversion (asterisks) 14 bases upstream of the start of exon 3 (indicated by
the boxed nucleotides, top right) of the Kdf1 (1810019J16Rik) transcript. (B) RT-PCR
across exons 2–4 of the Kdf1 transcript showing a single band in wild type and two
bands in shd homozygotes. (C) Representation of the splice variants in wild type
and shd mutant. The Kdf1 mRNA spans four exons (exon 2–4 are coding exons). The
shd mutation, a T4G transversion in intron 2, results in either a frame shift (splice
variant 1) or skipping of exon 3 altogether (splice variant 2). Blue: coding exons;
red: frame shift regions; white: untranslated regions. Arrows indicate the position
of primers used for RT-PCR in (B). (D) Schematic representation of the Kdf1 protein.
The predicted protein of Kdf1 does not contain conserved protein domains, except
slightly proline-rich (light blue) and cysteine-rich (gray) regions in the N-terminus
of the protein. The frame shift in the shd mutant isoform1 will result in a longer
protein with the C-terminal being out of frame (red). Alternatively, skipping of exon
3 will give rise to a truncated protein with a 24 amino acid in-frame deletion.
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between these possibilities, we performed a complementation test.
Brieﬂy, if the Kdf1GT allele was able to complement the shd mutant
allele when placed in trans and produce wild-type embryos, this
would indicate that the mutations affect different genes (Grifﬁths
et al., 2000). However, when we crossed Kdf1GT/þ heterozygotes
with shd/þ animals they failed to complement, with Kdf1GT/shd
transheterozygotes exhibiting the same phenotype as shd homo-
zygotes or Kdf1GT homozygotes. This included increased thickness of
the epidermis, a breakdown in the epidermal barrier and an
abnormal differentiation program in Kdf1GT/shd epidermis (Fig. 6A–
E). Together these data demonstrate that the shdmutant phenotype
is caused by a mutation in Kdf1.
Kdf1 is expressed throughout epidermal development.
In mature e18.5 mouse skin, we observed strongest expression
of Kdf1 transcripts in the basal and suprabasal layers of the
epidermis as well as within the developing hair follicles
(Fig. 7A). Kdf1 transcripts are also found in additional keratinocyte
populations, like those lining the lumen of the esophagus (Fig. 7B),
consistent with the defects observed in shd mutants. We con-
ﬁrmed Kdf1 expression using the LacZ gene within the genetrap
cassette in Kdf1GT carriers (Fig. 7C). The genetrap is expressed
in epidermis and hair follicles at e18.5 (Fig. 7D) and maintains
a similar pattern in adults (Fig. 7E) suggesting that it may
also function postnatally in maintenance or regeneration of the
epidermis.
To test where Kdf1 resides within cells, we used a commercial
antibody and analyzed Kdf1 localization in developing mouse
epidermis. In single layered keratinocytes (e12.5), the Kdf1 protein
is found throughout the epidermis in the cytoplasm and appeared
enriched at cell borders (Fig. 7F). After the onset of stratiﬁcation,
Kdf1 showed two distinct expression patterns, an enrichment at
cell borders in the basal and spinous layer, but becoming more
diffuse in more differentiated layers (Fig. 7G). This pattern is
disrupted in shd mutant epidermis and in Kdf1GT homozygous
animals (Supplemental Fig. 4). We also examined the localization
of endogenous Kdf1 in primary cultured mouse keratinocytes. We
found that Kdf1 is expressed at low levels, but strongest localiza-
tion occurred near the cell membrane, especially in cellular
protrusions (Fig. 7H). To verify that the antibody recognizes Kdf1,
we transfected keratinocytes with a GFP-tagged version of Kdf1
and found co-localization using the Kdf1 antibody and GFP
(Fig. 7I), although the pattern of high levels of overexpressed
Kdf1 was distinct from endogenous Kdf1. Cell protrusions had
highest levels of Kdf1 and using ﬂuorescently labeled phalloidin to
visualize F-actin we found that those Kdf1-positive protrusions
contained actin (Fig. 7J).
Discussion
The coordination of proliferation and differentiation is a funda-
mental process in all organisms. In multicellular organisms, pro-
liferation during early embryonic stages is critical to expand the
embryo while differentiation is needed to subfunctionalize tissues
and organs. Thus the balance between proliferation and differ-
entiation must be tightly coordinated to ensure stable size and
Fig. 7. Kdf1 is expressed in keratinocytes throughout epidermal development. (A) in situ hybridization shows Kdf1 transcripts in e18.5 epidermis with strongest expression in
the basal layer, including hair follicles (HF) and decreasing levels in differentiated layers. (B) Kdf1 transcripts are also found in other keratinocyte populations including the
esophagus at e18.5. (C) Simpliﬁed schematic of the genetrap inserted into the Kdf1 locus. The genetrap cassette lies between exons 1 (non-coding) and 2 (ﬁrst coding exon)
and is under the control of the endogenous Kdf1 promoter. The genetrap cassette contains a strong splice acceptor (SA), which is separated from a downstream LacZ cassette
by an IRES site. pA¼polyadenylation sequence. (D) X-Gal staining of e18.5 Kdf1GT heterozygous skin reveals a similar pattern as the Kdf1 transcript, with strong expression in
basal and suprabasal epidermal layers and hair follicles. (E) X-Gal staining adult Kdf1GT heterozygous tail skin shows continued Kdf1 locus expression in epidermis and hair
follicles. Kdf1 protein localizes to the cytoplasm and cell borders in single-layered epidermis at e12.5 (F) and retains this pattern in basal and spinous cells at e16.5 but is
more diffusely localized in the granular layer (G). Endogenous Kdf1 protein in cultured primary keratinocytes appears to be enriched at the leading edge and cell protrusions
(H). Overexpression of Kdf1-GFP in primary keratinocytes and co-staining with Kdf1 antibody supports the Kdf1 antibody speciﬁcity (I). Overexpression Kdf1-GFP co-
localizes with actin structures, recognized by Rhodamine–Phalloidin (J). β4 integrin staining marks the border between the epidermis and dermis (G). DAPI is shown in blue
(F–H). Scale bar represents 20 μm (A–D, H–J), 50 μm (E,D).
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function of organs and tissues. Deﬁning the factors that control the
rate of cell division and those that drive the decision of mitotically
active cells to differentiate is key to our understanding not only of
organ formation but also of tissue homeostasis and for deﬁning
the mechanisms underlying human disease.
Forward genetics provides a critical, unbiased, yet focused
approach to identify factors essential for the regulation of pro-
liferation and differentiation as well as other key cell fate deci-
sions. Human genetics studies have been greatly aided in recent
years by the use of targeted enrichment and next-generation
sequencing technologies to identify mutations underlying disease
syndromes. This and other recent studies demonstrate the poten-
tial for these techniques to transform model organism studies.
Selective, large-scale sequencing of mutants results in a rapid
progression from phenotype to affected gene, and facilitates
mutagenesis screens in mice as a tractable avenue for diagnostic
gene discovery.
In the present study, we used a forward genetic screen coupled
with sequence capture to identify a recessive mouse mutant (shd)
containing a splice site mutation in the previously unstudied Kdf1
(1810019J16Rik) gene (Fig. 5). We showed that Kdf1 is a key
inhibitor of cell proliferation and promoter of differentiation in
the epidermis (Fig. 2). We generated a gene trap allele of Kdf1
(Kdf1GT), which displayed a similar phenotype to shd mutants,
suggesting that shd is a loss of function allele of Kdf1. We then
veriﬁed that the splicing mutation in Kdf1 underlies the shd
phenotype by performing a complementation test with the Kdf1GT
allele (Fig. 6). We observed that Kdf1 is expressed in the epidermis
from early stages of embryonic development through adulthood,
and appears to localize to the cytoplasm of keratinocytes, with a
close association to the membrane (Fig. 7). We further show that
Kdf1 acts, at least in part, through the negative regulation of p63,
which is upregulated and expanded throughout the epidermis in
shd mutants instead of being restricted to the basal layer. The
increased p63 expression underlies many of the shd epidermal
defects including increased basal keratinoctye proliferation and
failure of distal epidermal cells to differentiate (Fig. 4).
Although the factors acting downstream of Kdf1 are unknown,
our genetic interaction data place Kdf1 upstream of p63 in
epidermal development, as reducing p63 gene dosage rescues
many of the epidermal defects in shd mutants. The divergent
subcellular localizations of p63 (nucleus) and Kdf1 (cytoplasmic)
suggest that Kdf1 acts indirectly to regulate p63 levels. One
attractive candidate for Kdf1 to act through is the Notch pathway,
due to the location of Notch receptors at the cell membrane. Notch
signaling antagonizes p63 and inhibits proliferation while promot-
ing differentiation (Estrach et al., 2008; Nguyen et al., 2006; Tadeu
and Horsley, 2013). However, the phenotypes of mice lacking
Notch signaling (Blanpain et al., 2006; Moriyama et al., 2008) are
much milder than we observed in either shd mutants or Kdf1GT
homozygotes, suggesting that if Kdf1 affects Notch signaling, it
must have other functions as well.
We further show that Kdf1 and Sfn genetically interact to
regulate the stepwise differentiation of keratinocytes (Fig. 3). In
animals doubly heterozygous for Kdf1 and Sfn mutations (shdþ /;
Erþ /), some regions of the epidermis showed expansion of p63
and distal keratinocytes retained basal markers in addition to
more differentiated markers, resulting in a breakdown in epider-
mal barrier formation. As Sfn is a key regulator of the cell cycle, it
will be important to determine if Kdf1 also functions by regulating
cell cycle progression in epidermal progenitor cells. Intriguingly,
mice with mutations in Ikkα or Irf6 phenocopy shd and Er
homozygotes. This raises the possibility that these four genes
might act in a common pathway to regulate stem cell proliferation
and differentiation (Hu et al., 1999; Ingraham et al., 2006; Li et al.,
1999; Richardson et al., 2006; Takeda et al., 1999). Notably, human
mutations in Irf6 and Ikka underlie the keratinocyte-related van
der Woude syndrome, Popliteal Pterygium syndrome, and Cocoon
syndrome (Kondo et al., 2002; Lahtela et al., 2010), highlighting
the importance of future efforts to deﬁne the organization of this
pathway for human health.
The human ortholog (C1Orf172) is also expressed in adult
epidermis (Uhlen et al., 2005) which suggests that Kdf1 has a
conserved function in mammalian keratinocytes and may continue
to function in adult epidermal maintenance. Together, our data
suggest a model where the shd gene product normally down-
regulates p63 in basal stem cells to maintain a speciﬁc prolifera-
tion rate. As cells exit the basal layer, the shd gene product acts
with Sfn, a known negative regulator of p63, to further down-
regulate p63 levels and promote differentiation and repression of
basal characteristics.
The shd mutant was ﬁrst identiﬁed at e12.5 based on the
observation that the snout and limbs were shorter (Fig. 1A–C). At
that early stage, the epidermis in wild-type animals is primarily
single-layered (Byrne et al., 1994; Lechler and Fuchs, 2005; Smart,
1970), while in shd mutants, the epidermis displays premature
formation of additional layers (Fig. 4A). However, the thickening of
the epidermis is not visible by wholemount examination of shd
mutants. This raises the question of whether the limb, snout and
epidermal phenotypes have the same root cause or reﬂect distinct
functions of the Kdf1 gene. It is unclear what causes the short
snout phenotype; however it is known that digit length is
regulated by a stratiﬁed epithelia signaling center called the apical
ectodermal ridge (AER) that forms at the distal edge of the limb
(Saunders, 1948; Summerbell, 1974; Sun et al., 2002). We have
observed defects in the organization of the (AER) in shd mutants
(Lee & Weatherbee, unpublished results), suggesting that Kdf1 acts
in multiple stratiﬁed epithelia including the epidermis and AER.
Interestingly, p63 also functions in the AER and is required for
normal limb development in mice (Mills et al., 1999; Yang et al.,
1999) and humans (Amiel et al., 2001; Celli et al., 1999; Duijf et al.,
2002; Ianakiev et al., 2000; McGrath et al., 2001; van Bokhoven
et al., 2001). Although beyond the scope of this study, it will be
important to determine whether Kdf1 also functions in the AER to
regulate p63, or if Kdf1 acts through a different mechanism in the
limb. These studies could uncover a role for Kdf1 as a modiﬁer of
human syndromes associated with p63 including Split Hand–Foot
Malformation, Ectrodactyly, Ectodermal dysplasia and Cleft lip/
palate syndrome, Limb mammary syndrome, Ankyloblepharon-
Ectodermal defects-Clefting syndrome and Acro-Dermato-Ungual-
Lacrimal-Tooth syndrome
Our ﬁndings provide the ﬁrst evidence that the novel gene Kdf1
(1810019J16Rik) functions as a critical regulator of proliferation and
differentiation in epidermal progenitor cells and thus has potential
broad implications for the understanding of tissue morphogenesis,
homeostasis and cancer. While both the shd and gene trap alleles
of Kdf1 are perinatal lethal, it will be useful to determine whether
Kdf1 is required postnatally for epidermal maintenance. The
continued expression of Kdf1 in adult epidermis (Fig. 7E), suggests
that Kdf1 may play a similar role in controlling adult epidermal
cells proliferation and differentiation.
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